| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Absorption, Distribution, Metabolism, and Excretion (ADME) Studies of Biotherapeutics for Autoimmune and Inflammatory Conditions
|
Vugmeyster, Yulia
|
|
2012
|
14 |
4 |
p. 714-727
|
artikel
|
| 2 |
ADME of Antibody–Maytansinoid Conjugates
|
Erickson, Hans K.
|
|
2012
|
14 |
4 |
p. 799-805
|
artikel
|
| 3 |
A One-Step Solid Phase Extraction Method for Bioanalysis of a Phosphorothioate Oligonucleotide and Its 3′ n-1 Metabolite from Rat Plasma by uHPLC–MS/MS
|
Chen, Buyun
|
|
2012
|
14 |
4 |
p. 772-780
|
artikel
|
| 4 |
Bioequivalence Requirements in the European Union: Critical Discussion
|
García-Arieta, Alfredo
|
|
2012
|
14 |
4 |
p. 738-748
|
artikel
|
| 5 |
Challenges and Opportunities in Absorption, Distribution, Metabolism, and Excretion Studies of Therapeutic Biologics
|
Xu, Xin
|
|
2012
|
14 |
4 |
p. 781-791
|
artikel
|
| 6 |
Characterising Lipid Lipolysis and Its Implication in Lipid-Based Formulation Development
|
Thomas, Nicky
|
|
2012
|
14 |
4 |
p. 860-871
|
artikel
|
| 7 |
Characterization of Supersaturatable Formulations for Improved Absorption of Poorly Soluble Drugs
|
Gao, Ping
|
|
2012
|
14 |
4 |
p. 703-713
|
artikel
|
| 8 |
Crystalline Nanosuspensions as Potential Toxicology and Clinical Oral Formulations for BCS II/IV Compounds
|
Kesisoglou, Filippos
|
|
2012
|
14 |
4 |
p. 677-687
|
artikel
|
| 9 |
Drug Repurposing: Far Beyond New Targets for Old Drugs
|
Oprea, T. I.
|
|
2012
|
14 |
4 |
p. 759-763
|
artikel
|
| 10 |
Effective Absorption Modeling in Relative Bioavailability Study Risk Assessment
|
Rose, John P.
|
|
2012
|
14 |
4 |
p. 895-903
|
artikel
|
| 11 |
Effect of Device Design on the In Vitro Performance and Comparability for Capsule-Based Dry Powder Inhalers
|
Shur, Jagdeep
|
|
2012
|
14 |
4 |
p. 667-676
|
artikel
|
| 12 |
Engineered Nanoparticulate Drug Delivery Systems: The Next Frontier for Oral Administration?
|
Diab, Roudayna
|
|
2012
|
14 |
4 |
p. 688-702
|
artikel
|
| 13 |
Evaluation of a Catenary PBPK Model for Predicting the In Vivo Disposition of mAbs Engineered for High-Affinity Binding to FcRn
|
Chen, Yang
|
|
2012
|
14 |
4 |
p. 850-859
|
artikel
|
| 14 |
Evaluation of an Innovative Population Pharmacokinetic-Based Design for Behavioral Pharmacodynamic Endpoints
|
Viberg, Anders
|
|
2012
|
14 |
4 |
p. 657-663
|
artikel
|
| 15 |
Functional and Molecular Aspects of Biotin Uptake via SMVT in Human Corneal Epithelial (HCEC) and Retinal Pigment Epithelial (D407) Cells
|
Vadlapudi, Aswani Dutt
|
|
2012
|
14 |
4 |
p. 832-842
|
artikel
|
| 16 |
Guidelines for the Quality Control of Population Pharmacokinetic–Pharmacodynamic Analyses: an Industry Perspective
|
Bonate, P. L.
|
|
2012
|
14 |
4 |
p. 749-758
|
artikel
|
| 17 |
Implementation of a Reference-Scaled Average Bioequivalence Approach for Highly Variable Generic Drug Products by the US Food and Drug Administration
|
Davit, Barbara M.
|
|
2012
|
14 |
4 |
p. 915-924
|
artikel
|
| 18 |
International Veterinary Bioequivalence Guideline Similarities and Differences Between Australia, Canada, Europe, Japan, New Zealand and the United States
|
Lainesse, Chantal
|
|
2012
|
14 |
4 |
p. 792-798
|
artikel
|
| 19 |
Metrics for the Evaluation of Bioequivalence of Modified-Release Formulations
|
Endrenyi, Laszlo
|
|
2012
|
14 |
4 |
p. 813-819
|
artikel
|
| 20 |
Monoamine Transporter Structure, Function, Dynamics, and Drug Discovery: A Computational Perspective
|
Manepalli, Sankar
|
|
2012
|
14 |
4 |
p. 820-831
|
artikel
|
| 21 |
Pharmacokinetics and Tissue Disposition of Lenalidomide in Mice
|
Rozewski, Darlene M.
|
|
2012
|
14 |
4 |
p. 872-882
|
artikel
|
| 22 |
Phosphorothioate Oligonucleotide Quantification by μ-Liquid Chromatography-Mass Spectrometry
|
Erb, Robert
|
|
2012
|
14 |
4 |
p. 728-737
|
artikel
|
| 23 |
Rationalizing Structure and Target Relationships between Current Drugs
|
Hu, Ye
|
|
2012
|
14 |
4 |
p. 764-771
|
artikel
|
| 24 |
Regulatory Pathways for ATP-binding Cassette Transport Proteins in Kidney Proximal Tubules
|
Masereeuw, Rosalinde
|
|
2012
|
14 |
4 |
p. 883-894
|
artikel
|
| 25 |
Semi-mechanistic Modeling of the Interaction Between the Central and Peripheral Effects in the Antinociceptive Response to Lumiracoxib in Rats
|
Vélez de Mendizábal, Nieves
|
|
2012
|
14 |
4 |
p. 904-914
|
artikel
|
| 26 |
Shrinkage in Nonlinear Mixed-Effects Population Models: Quantification, Influencing Factors, and Impact
|
Xu, Xu Steven
|
|
2012
|
14 |
4 |
p. 927-936
|
artikel
|
| 27 |
Statistics on BCS Classification of Generic Drug Products Approved Between 2000 and 2011 in the USA
|
Nair, Anil K.
|
|
2012
|
14 |
4 |
p. 664-666
|
artikel
|
| 28 |
Universal Immunoassay Applied During Early Development of Large Molecules to Understand Impact of Immunogenicity on Biotherapeutic Exposure
|
Bautista, Ami C.
|
|
2012
|
14 |
4 |
p. 843-849
|
artikel
|
| 29 |
Use of Partial Area under the Curve Metrics to Assess Bioequivalence of Methylphenidate Multiphasic Modified Release Formulations
|
Stier, Ethan M.
|
|
2012
|
14 |
4 |
p. 925-926
|
artikel
|
| 30 |
Variation of Stratum Corneum Biophysical and Molecular Properties with Anatomic Site
|
Mohammed, Diar
|
|
2012
|
14 |
4 |
p. 806-812
|
artikel
|
Tijdschrift beschrijving